0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Original Investigation |  FREE ONLINE FIRST
Yilong Wang, MD, PhD; Xingquan Zhao, MD, PhD; Jinxi Lin, MD, PhD; et al.
JAMA. Published online June 23, 2016. doi:10.1001/jama.2016.8662
Includes: Supplemental Content

Viewpoint | 
Arjun K. Manrai, PhD; John P. A. Ioannidis, MD, DSc; Isaac S. Kohane, MD, PhD
JAMA. 2016;315(12):1233-1234. doi:10.1001/jama.2016.1519.

JAMA Diagnostic Test Interpretation | 
Talal Hilal, MD; Edward H. Romond, MD
JAMA. 2016;315(12):1280-1281. doi:10.1001/jama.2015.17463.

Lab Reports | 
Tracy Hampton, PhD
JAMA. 2016;315(9):860. doi:10.1001/jama.2016.1486.

Health Agencies Update | 
Julie A. Jacob, MA
JAMA. 2016;315(8):741. doi:10.1001/jama.2016.0559.

Viewpoint | 
Glenn S. Gerhard, MD; Barbara Paynton, PhD; Steven N. Popoff, PhD
JAMA. 2016;315(6):555-556. doi:10.1001/jama.2015.19465.

Medical News & Perspectives | 
Tracy Hampton, PhD
JAMA. 2016;315(6):546-548. doi:10.1001/jama.2015.19150.

Health Agencies Update | 
Julie A. Jacob, MA
JAMA. 2015;314(24):2607. doi:10.1001/jama.2015.17173.

Health Agencies Update | 
Julie A. Jacob, MA
JAMA. 2015;314(20):2121. doi:10.1001/jama.2015.15305.

Viewpoint | 
Michael J. Joyner, MD; Nigel Paneth, MD, MPH
JAMA. 2015;314(10):999-1000. doi:10.1001/jama.2015.7725.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Oncology
Invited Commentary  | 
Cardiac Protection in HER2-Targeted Treatment How Should We Measure New Strategies?
Ana Barac, MD, PhD; Sandra M. Swain, MD
JAMA Cardiology
Original Investigation  | 
Genetic Investigation Into the Differential Risk of Atrial Fibrillation Among Black and White Individuals
Jason D. Roberts, MD, MAS; Donglei Hu, PhD; Susan R. Heckbert, MD, PhD; et al.
JAMA Neurology
Editorial  | 
Disentangling (Epi)Genetic and Environmental Contributions to the Mitochondrial 3243A>G Mutation Phenotype Phenotypic Destiny in Mitochondrial Disease?
Martin Picard, PhD; Michio Hirano, MD
JAMA Oncology
Research Letter  | 
Clinical Validation of Chemotherapy Response Biomarker ERCC2 in Muscle-Invasive Urothelial Bladder Carcinoma
David Liu, MD, MPH, MS; Elizabeth R. Plimack, MD, MS; Jean Hoffman-Censits, MD; et al.